Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lize Kiakouama

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Respiratory Medicine Case Reports|January 3, 2022
A challenging case of thoracic empyema caused by <i>Prevotella</i> sppRémi Diesler, Lize Kiakouama-Maleka
European Journal of Case Reports in Internal Medicine|November 13, 2025
Sudden-Onset Platypnea-Orthodeoxia Syndrome in a Patient with Lung Adenocarcinoma and COVID-19 Without a Patent Foramen OvaleTanguy Espejo, Lize Kiakouama, Reto Etter, et al.
Presse Medicale (Paris, France : 1983)|May 4, 2011
[Pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011?]Vincent Cottin, Lize Kiakouama, Julie Traclet, et al.
Respiratory Medicine|April 2, 2011
Conditions associated with severe carbon monoxide diffusion coefficient reductionLize Kiakouama, Vincent Cottin, Jean-Charles Glerant, et al.
Autoimmunity Reviews|September 17, 2020
Sarcoidosis after breast implant rupture: Looking beyond granulomasAntoine Gavoille, Michel Vincent, Lize Kiakouama, et al.
BMJ Open Respiratory Research|January 22, 2025
Twelve barriers to COPD diagnosis in France: a comparative qualitative studyGuillaume Roucoux, Elisabetta Scanferla, Mathieu Delorme, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life settingPauline Corbaux, Denis Maillet, Amélie Boespflug, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2020
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitorsDenis Maillet, Pauline Corbaux, Jean-Jacques Stelmes, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2021
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trialArmelle Lavole, Julien Mazieres, Sophie Schneider, et al.
BMC Infectious Diseases|December 15, 2018
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunityJudith Provoost, Florent Valour, Delphine Gamondes, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Respiratory Medicine Case Reports|January 3, 2022
A challenging case of thoracic empyema caused by <i>Prevotella</i> sppRémi Diesler, Lize Kiakouama-Maleka
European Journal of Case Reports in Internal Medicine|November 13, 2025
Sudden-Onset Platypnea-Orthodeoxia Syndrome in a Patient with Lung Adenocarcinoma and COVID-19 Without a Patent Foramen OvaleTanguy Espejo, Lize Kiakouama, Reto Etter, et al.
Presse Medicale (Paris, France : 1983)|May 4, 2011
[Pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011?]Vincent Cottin, Lize Kiakouama, Julie Traclet, et al.
Respiratory Medicine|April 2, 2011
Conditions associated with severe carbon monoxide diffusion coefficient reductionLize Kiakouama, Vincent Cottin, Jean-Charles Glerant, et al.
Autoimmunity Reviews|September 17, 2020
Sarcoidosis after breast implant rupture: Looking beyond granulomasAntoine Gavoille, Michel Vincent, Lize Kiakouama, et al.
BMJ Open Respiratory Research|January 22, 2025
Twelve barriers to COPD diagnosis in France: a comparative qualitative studyGuillaume Roucoux, Elisabetta Scanferla, Mathieu Delorme, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2019
Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life settingPauline Corbaux, Denis Maillet, Amélie Boespflug, et al.
European Journal of Cancer (Oxford, England : 1990)|April 26, 2020
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitorsDenis Maillet, Pauline Corbaux, Jean-Jacques Stelmes, et al.
Lung Cancer (Amsterdam, Netherlands)|July 4, 2021
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trialArmelle Lavole, Julien Mazieres, Sophie Schneider, et al.
BMC Infectious Diseases|December 15, 2018
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunityJudith Provoost, Florent Valour, Delphine Gamondes, et al.
Pageof 2